A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.
Financial Summary
| Share Statistics | DSFIY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $26,530.7 | $3,722.6 | 89% |
|
| Shares Out (Mil) | 285.8 | 87.3 | 82% |
|
| Institutional Ownership | 36.2% | 87.5% | 16% |
|
| Float (Mil) | 214.3 | 117.5 | 75% |
|
| Beta | 0.55 | 0.80 | 31% |
|
| Avg Daily Volume (000s) | 308 | 176 | 51% |
|
| Price Change (52-week) |
11.6% | 81.7% | 55% |
|
| Growth | DSFIY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.4% | 4.2% | 21% |
|
| Net Income (5yr) | (32.3%) | 1.4% | 12% |
|
| EPS (5yr) | (27.9%) | 3.2% | 9 |
|
| Dividends (5yr) | 0.0% | 0.0% | 94% |
|
| Cash Flow (5yr) | (59.2%) | (15.3%) | 4% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | DSFIY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $10,345 | $3,981 | 84% |
|
| Net Income (TTM) (Mil) | ($1,576) | $70 | 1% |
|
| EPS (TTM) | ($6.353) | $0.400 | 6% |
|
| Operating Cash Flow (TTM) (Mil) | $1,885 | $388 | 87% |
|
| Net Cash Flow (TTM) (Mil) | na | $9 | na |
|
| Long-Term Debt (Q1) (Mil) | $5,843 | $1,682 | 87% |
|
| Enterprise Value (Q1) (Mil) | $31,534 | $5,497 | 88% |
|
| Valuation | DSFIY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.48 | na |
|
| P/E | na | 24.8 | na |
|
| Dividend Yield | na | 1.3% | na |
|
| PEG (5yr hist) | na | 2.0 | na |
|
| Ratios | DSFIY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 39.2% | 29.8% | 49% |
|
| Net Margin | (15.2%) | 2.8% | 18% |
|
| ROA | (4.3%) | 2.1% | 31% |
|
| ROE | (6.9%) | 4.8% | 30% |
|
| Liabilities to Assets | 41.0% | 53.6% | 32% |
|
| F-Score | na | 5 | na |
|
DSM-Firmenich AG did not pass any screens on 7/31/2026.
